Ceva Establishes Canadian Operations

Posted: Oct. 3, 2011, 7:15 p.m., EDT



Published:

Ceva has acquired two Canadian companies as part of plans to build a broad-based Canadian animal health business.

French animal health company Ceva Sante Animale acquired a pair of Canadian companies, Ceva reported today.

Ceva acquired veterinary product manufacturer and distributor CentaurVA Animal Health and poultry vaccine manufacturer Vetech Laboratories, both of Guelph, Ontario.

“Canada is an important world economy where we needed to have a direct presence,” said Marc Prikazsky, CEO of Ceva.

Ceva previously had a limited presence in Canada, according to Craig Wallace, North America Zone Director for Ceva. The acquisitions establish a foundation for Ceva’s plan to build a broad-based Canadian animal health business, Wallace added.

Centaur manufactures and distributes products for small and large animal veterinary practitioners, including nutraceuticals, joint therapies and infection-control products.

“[The Centaur acquisition] helps in marketing and distributing current Ceva products and will serve as a strong foundation for future product launches,” Wallace said.

Vetech produces live coccidiosis vaccines for poultry under the trade name Immucox. Production of Immucox will remain primarily in Canada, but Ceva will improve the vaccine through the company’s technology and expertise in the field of poultry health, Wallace said.

The terms of the deals were not disclosed.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Study May Lead to Early Diagnosis of Feline Kidney Disease

The biomarker SDMA identified the onset of kidney disease an average of 17 months earlier in cats and in one case four years earlier.

Merck Launches Overseas Veterinarian Exchange

The Nobivac Global Vet Exchange Program allows practitioners to observe how veterinary medicine is performed in other countries.

Petco Buying Drs. Foster and Smith

Co-founders Race Foster and Marty Smith will stay with Drs. Foster and Smith when Petco takes ownership and branches into drug sales in early 2015.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module